MARKET

CMPS

CMPS

Compass Pathways Plc
NASDAQ
3.910
+0.120
+3.17%
After Hours: 3.880 -0.03 -0.77% 17:00 05/12 EDT
OPEN
4.000
PREV CLOSE
3.790
HIGH
4.030
LOW
3.865
VOLUME
587.55K
TURNOVER
--
52 WEEK HIGH
8.54
52 WEEK LOW
2.490
MARKET CAP
365.83M
P/E (TTM)
-2.0060
1D
5D
1M
3M
1Y
5Y
1D
Compass Pathways Price Target Maintained With a $45.00/Share by HC Wainwright & Co.
Dow Jones · 12h ago
HC Wainwright & Co. Reiterates Buy on Compass Pathways, Maintains $45 Price Target
Benzinga · 12h ago
Analysts Have Conflicting Sentiments on These Healthcare Companies: COMPASS Pathways (CMPS), Liquidia Technologies (LQDA) and Regulus (RGLS)
TipRanks · 13h ago
Buy Rating Reiterated for COMPASS Pathways: Promising Phase 3 Trials and Strong Financial Position Highlighted
TipRanks · 13h ago
Weekly Report: what happened at CMPS last week (0505-0509)?
Weekly Report · 14h ago
Compass Pathways Reports Improved Quarterly Results
TipRanks · 3d ago
Compass Pathways’ Earnings Call Highlights Progress and Challenges
TipRanks · 3d ago
Positive Outlook for COMPASS Pathways: Strong Clinical Progress and Financial Stability Support Buy Rating
TipRanks · 4d ago
More
About CMPS
More
Compass Pathways plc is a United Kingdom-based biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health. The Company is engaged in the development of psilocybin treatment, in which its investigational COMP360 psilocybin is administered in conjunction with psychological support, COMP360 psilocybin treatment. COMP360 is its proprietary psilocybin formulation that includes its pharmaceutical-grade polymorphic crystalline psilocybin, optimized for stability and purity. The Company’s initial focus is on treatment-resistant depression (TRD), comprising patients who are inadequately served by the current treatment paradigm. It commenced its Phase III program evaluating its COMP360 psilocybin treatment in TRD. In addition, the Company has ongoing Phase II trials in PTSD and anorexia nervosa. It also provides support to research institutions conducting investigator-initiated studies with COMP360 psilocybin in areas of serious unmet need.
Recently
Symbol
Price
%Change

Webull offers Compass Pathways PLC (ADR) stock information, including NASDAQ: CMPS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CMPS stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CMPS stock methods without spending real money on the virtual paper trading platform.